Feedback / Questions
HER2Bi-armed ATC - TransTarget, Barbara Ann Karmanos Cancer Institute
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03406858
Nov 15, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next